Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates
JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides […]
Lesaka – Availability of materials for March 31, 2025 Investor Day
JOHANNESBURG, March 28, 2025 (GLOBE NEWSWIRE) — Lesaka Technologies, Inc. (NASDAQ:LSAK, JSE: LSK) (“Lesaka” or the “Company”) today announced that […]
Ambow Files Annual Report on Form 20-F for Fiscal Year 2024
CUPERTINO, California, March 28, 2025 (GLOBE NEWSWIRE) — Ambow Education Holding Ltd. (NYSE American: AMBO) (“Ambow” or the “Company”), an […]
Conifer Holdings Reports 2024 Fourth Quarter and Year End Financial Results
TROY, Mich., March 28, 2025 (GLOBE NEWSWIRE) — Conifer Holdings, Inc. (Nasdaq: CNFR) (“Conifer” or the “Company”) today announced results […]
Medallion Bank Announces Benchmark Rate for Certain Preferred Stock
SALT LAKE CITY, March 28, 2025 (GLOBE NEWSWIRE) — Medallion Bank (Nasdaq: MBNKP, the “Bank”) today announced that, upon the […]
Aureus Greenway Holdings Inc. Releases Fiscal Year 2024 Financial Results
Kissimmee, FL, March 28, 2025 (GLOBE NEWSWIRE) — Aureus Greenway Holdings Inc. (the “Company”) (NASDAQ: AGH), announced today that it […]
Xos, Inc. Reports Record-Breaking 2024 with Growing Unit Deliveries and Highest-Ever Gross Profit
Achieved $3.3 million of net cash provided by operating activities, and our first quarter of positive Free Cash Flow of […]
Safety Shot, Inc. Announces Record Date for Spin-Off and Distribution of Shares Common Stock of Caring Brands, Inc.
JUPITER, FL, March 28, 2025 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”), today announced […]
RCP Small and Emerging Fund III, LP Closes on ~$170 Million
CHICAGO, March 28, 2025 (GLOBE NEWSWIRE) — RCP Advisors, a private equity investment firm that provides access to North American […]
HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results
MIRAMAR, Fla., March 28, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage […]
